We believe that the role of NEK6 in other prostate cancer cell lines should be further investigated, but our present data point out an important role of NEK6 in cisplatin sensitivity and as a co-adjuvant therapy for prostate cancer treatment. Here, NEK6 is linked to Familial prostate cancer.